Cranex: 14.5L equity shares allotted on warrant conversion; capital raised Rs. 11.09 Cr
FUNDRAISE
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 24 Apr 2026, 06:19 PM IST · BSE ID: e7378e46-a90d-4f2c-ac3a-97ef922be1b9
View Original BSE Filing (PDF)
💡
In Simple Terms
Cranex converted warrants into 14.5 lakh new shares, raising Rs. 11 crore, with promoters and outside investors receiving allocations.
🤖 AI Summary
- Cranex allotted 14,50,000 equity shares at Rs. 102/- each upon warrant conversion on April 24, 2026
- Total fundraise aggregated Rs. 11,09,25,000/- via balance amount receipt at Rs. 76.50/- per warrant
- Promoter Chaitanya Agrawal shareholding increased from 2.89% to 7.36%; Amitabh Agrawal entered with 3.74%
- Non-promoter Securocrop Securities India received 4,00,000 shares (4.99% post-allotment stake)
- 7,60,000 warrants by other subscribers forfeited for non-exercise within 18-month deadline ending April 24, 2026
🔢 Key Numbers — exact figures from BSE filing, not rounded
Equity shares allotted
14,50,000 shares
Issue price per share
Rs. 102/- (premium Rs. 92/-)
Total fundraise
Rs. 11,09,25,000/-
Paid-up equity capital post-allotment
Rs. 8,02,00,000 (80,20,000 shares @ Rs. 10/- FV)
Warrants forfeited
7,60,000 (18-month non-exercise deadline)
Chaitanya Agrawal shareholding increase
2.89% to 7.36%
🏢 How This Affects the Company
Paid-up equity capital increased from Rs. 6,57,00,000 to Rs. 8,02,00,000. Total gross fundraise of Rs. 11,09,25,000/- received via warrant conversion exercise.
Warrant forfeiture of Rs. 5,83,00,000 (7,60,000 warrants × Rs. 76.50 per warrant) represents capital deployed by lapsed subscribers now retained by company. Share capital expansion increases complexity of future fundraise pricing.
👥 What This Means For Shareholders
✅
Action Required
Existing shareholders holding before April 24, 2026 should verify dematerialized account credits of 14,50,000 new shares and monitor next dividend ex-date for pari-passu entitlements.
👤
Who Is Affected
All existing equity shareholders face 21.22% (14,50,000 ÷ 80,20,000) dilution of voting power post-allotment. Promoter shareholding consolidated; non-promoter collective stake increased to ~10.62%. Warrant forfeiture holders lose all claim.
🔍
Management Signal
Board prioritized capital infusion over maintaining restrictive warrant windows, signalling intent to fund growth initiatives rather than retain optionality for original warrant subscribers.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Check next shareholding pattern filing under Reg 31 for complete promoter/non-promoter breakdown post-allotment.
Monitor next Board meeting for dividend declaration; new share capital base will determine total distribution quantum.
Track next financial results for cash burn rate and whether Rs. 11 Cr capital deployed towards growth or debt repayment.
MEDIUM RISK
Large warrant forfeiture (72.39% lapse rate) signals weak subscriber conviction. Significant new capital injection without disclosure of deployment plan raises utilization risk.
💡 Investor Takeaway
Cranex completed warrant-to-equity conversion of 14,50,000 shares at Rs. 102/- each, aggregating Rs. 11,09,25,000/-. Promoter combined stake increased to 11.10% post-allotment. However, 72.39% of original warrant holders forfeited positions, suggesting execution headwinds.
⚖️ Strengths & Concerns
✅ Positives
- Successful full conversion of 14,50,000 warrants at Rs. 102/- per share, confirming investor confidence in valuation
- Diversified shareholder base: promoters 47.10% of new allotment; non-promoters 52.90% ensures institutional participation
⚠️ Concerns
- 72.39% of original warrant holders (7,60,000 of 27,80,000) did not exercise conversion within 18-month window
- 7,60,000 warrant forfeiture amounts to Rs. 5,83,00,000 in capital non-deployment, signalling weak investor conviction among non-converting holders
📅 Company Track Record
Company incorporated and listed on BSE (Scrip 522001). Warrants allotted October 25, 2024 (27,80,000 units at Rs. 102/- per warrant). Conversion exercise window: 18 months from allotment. No prior BSE filing disclosures available for financial trend analysis.
Based on publicly available historical data. For context only.